Delivery Order SPE2DB22D2206-SPE2DB25FGT12

Award Date 4/25/25
Potential Completion Date 4/28/25
Potential Value $2.7K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,303.72, is a delivery order for the supply of 4,567,915,590 units of the medication Clobazam 10 mg Tablet. The contract has a firm fixed price and an ultimate completion date of April 16, 2025. This contract is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,111.86, is for the delivery of 4,567,982,964 units of the prescription medication Clobazam 10 mg Tablet. It is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2025. The contract is not set aside and was openly competed. AmerisourceBergen Drug Corp holds...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,555.93, is for the delivery of 4,567,841,426 units of the drug Clobazam 10 mg tablets. The contract type is a Delivery Order with a Firm Fixed Price pricing arrangement, and the ultimate completion date is April 9, 2025. The contract was awarded on April 8, 2025 and does not have a set-aside...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,820.13 for the supply of 4,565,563,070 units of the prescription drug Clobazam 10 mg tablet. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of August 26, 2024. The contract is a firm fixed-price delivery order and does not utilize any set-aside designations. AmerisourceBergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,667.79 firm fixed-price delivery order is for the supply of 4,567,039,867 units of the drug Clobazam 10 mg tablets. The contract has an ultimate completion date of January 27, 2025 and was awarded on January 24, 2025. This contract award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that...
This federal contract award, valued at $15,663.54, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The award is for the delivery of 4,563,667,437 units of the pharmaceutical product Clobazam 10 mg Tablet, with a completion date of February 15, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical...
This federal contract award, valued at $9,335.58, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,931,170 units of the drug Clobazam 10 mg Tablet in 100-count packages. The contract has a period of performance through January 15, 2025 and does not have a set-aside designation, indicating it was awarded through open competition. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,619.69, is for the delivery of 4,567,887,267 tablets of the drug clobazam 10 mg. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of April 14, 2025. The contract was awarded on April 11, 2025 and does not have a set-aside designation. AmerisourceBergen holds a...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $38,132.10, is for the delivery of 4,567,729,276 units of the prescription drug Clobazam 10 mg Tablet. The contract has a period of performance through March 31, 2025 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen holds...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,676.49 firm fixed-price delivery order is for the supply of 4,566,186,788 tablets of the prescription medication Clobazam 10 mg. The contract has an ultimate completion date of October 24, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FGT12
    Delivery Order

This federal contract award, valued at $2,694.35, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,039,784 units of the prescription medication Clobazam 10 mg tablets in 100-count bottles. The contract is a firm-fixed-price delivery order with an ultimate completion date of April 28, 2025. This award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp is the prime contractor and does not have any listed major subcontractors. The contract is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides comprehensive global pharmaceutical support to military healthcare programs and other government agencies through December 2026.

Generated 7/25/25, 11:13 AM